2I4Q

Human renin/PF02342674 complex


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.3 Å
  • R-Value Free: 0.261 
  • R-Value Work: 0.229 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history

Literature

Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors.

Powell, N.A.Ciske, F.L.Cai, C.Holsworth, D.D.Mennen, K.Van Huis, C.A.Jalaie, M.Day, J.Mastronardi, M.McConnell, P.Mochalkin, I.Zhang, E.Ryan, M.J.Bryant, J.Collard, W.Ferreira, S.Gu, C.Collins, R.Edmunds, J.J.

(2007) Bioorg.Med.Chem. 15: 5912-5949

  • DOI: 10.1016/j.bmc.2007.05.069

  • PubMed Abstract: 
  • We report the design and synthesis of a series of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as orally bioavailable small molecule inhibitors of renin. Compounds with a 2-methyl-2-aryl substitution pattern exhibit potent renin inhibition and go ...

    We report the design and synthesis of a series of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as orally bioavailable small molecule inhibitors of renin. Compounds with a 2-methyl-2-aryl substitution pattern exhibit potent renin inhibition and good permeability, solubility, and metabolic stability. Oral bioavailability was found to be dependent on metabolic clearance and cellular permeability, and was optimized through modulation of the sidechain that binds in the S3(sp) subsite.


    Organizational Affiliation

    Pfizer Global Research & Development, Michigan Laboratories, Ann Arbor, MI 48105, USA. powellns@netzero.com




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Renin
A, B
336Homo sapiensMutation(s): 0 
Gene Names: REN
EC: 3.4.23.15
Find proteins for P00797 (Homo sapiens)
Go to Gene View: REN
Go to UniProtKB:  P00797
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
UA4
Query on UA4

Download SDF File 
Download CCD File 
A, B
(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2-METHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE
C25 H27 F2 N5 O3
UAXNNGUDPWZOKX-VWLOTQADSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
UA4ΔG: -38.8 kJ/mol (100) BINDINGDB
UA4IC50: 7 - 7.1 nM (100) BINDINGDB
UA4IC50: 7 nM BINDINGMOAD
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.3 Å
  • R-Value Free: 0.261 
  • R-Value Work: 0.229 
  • Space Group: P 21 3
Unit Cell:
Length (Å)Angle (°)
a = 141.898α = 90.00
b = 141.898β = 90.00
c = 141.898γ = 90.00
Software Package:
Software NamePurpose
REFMACrefinement
CNSphasing
PDB_EXTRACTdata extraction
ADSCdata collection
HKL-2000data scaling
HKL-2000data reduction

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2006-10-24
    Type: Initial release
  • Version 1.1: 2008-05-01
    Type: Version format compliance
  • Version 1.2: 2011-07-13
    Type: Version format compliance